Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.
Aphakia clinical trials
2 of 6 indexed Aphakia trials are currently recruiting.
Corpus placement: #2,866 of 28,707 conditions by registered trial count.
6 US clinical trials · 2 currently recruiting · #2,866 of 28,707 conditions by registered trial count
Aphakia: 6 US clinical trials tracked, 2 recruiting.
Aphakia is the subject of 6 registered US clinical trials on ClinicalTrials.gov, 2 of them currently open to new participants. The most active sponsor is Alcon Research, running 5 of these trials.
Enrollment posture brief
Registry condition aphakia
OPEN 2 | RECR 33% | LATE 0 | EARLY 0 | RANK #2866 | SPON 5
Volume-matched condition peers
Nearest open-share peer: Adherence, Treatment (33% recruiting · 6 trials)
Aphakia lists 2 open slots (33% of 6 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →
Key findings
What ClinicalTrials.gov does not surface for Aphakia on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.
-
Aphakia is recruiting below its size-band peers.
2 of 6 indexed trials (33.3%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.
-
One sponsor concentrates Aphakia research.
Alcon Research accounts for 5 of 6 trials (83.3%). 2 distinct sponsors appear on at least one study for this condition label.
-
Typical Aphakia enrolment sits around 125 participants.
Median target enrolment is 125 among the 6 trials that report a genuine target (sentinel values excluded). 2 of those (33.3%) plan for fewer than 100 participants.
-
Aphakia research is mostly interventional.
6 interventional and 0 observational studies make up this index (100% interventional). Study type is sponsor-reported on ClinicalTrials.gov.
Open and recent trials
6 total, page 1 of 1
Post Market Clinical Evaluation of Clareon PanOptix Pro and Clareon PanOptix Pro Toric IOLs
Alcon Research
NCT07161635
Feasibility Study of an Accommodating IOL Design
Alcon Research
NCT07147192
Post Market Clinical Follow-up (PMCF) Study of Clareon Vivity & Clareon PanOptix
Alcon Research
NCT05796453
Clareon Toric vs Eyhance Toric
Alcon Research
NCT05481125
Comparison of the Hoya Surgical Optics (HSO) iSert 251 Posterior Chamber Aspheric Aphakic Intraocular Lens to Historical / Literature Controls.
Hoya Surgical Optics
NCT01292629
Clareon PanOptix Pro vs. Clareon PanOptix - Study B
Alcon Research
NCT06401551
Phase Distribution
Phase data not available
Top Sponsors
Named interventions
Most-linked intervention names on Aphakia records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.
US sites by state
Facility locations filed on Aphakia trials. A trial with sites in several states counts in each.
Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.
Related
What to do with this Aphakia page
6 registered trials, 2 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.
- 2 Aphakia trials are currently recruiting, check eligibility criteria before contacting a site. Browse recruiting trials
- Alcon Research sponsors the most Aphakia trials on record, review their full trial history before evaluating a specific study. See Alcon Research's trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Aphakia condition card totals 6 registered trials; most-linked intervention Phacoemulsification; top US site state Texas. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.